Dorian Therapeutics, Inc

Augmenta Bioworks, located in Menlo Park, CA, is dedicated to building global immunity to disease by discovering new therapeutics that harness the power of natural human immunity. Their technology identifies specific immune responses and translates these findings into therapies that can benefit the broader population. Utilizing advanced methods such as automation, microfluidics, high-throughput DNA sequencing, and scalable computational analysis, Augmenta facilitates the discovery of immune receptors and their antigen specificity. Collaborating with pharmaceutical and biotechnology companies, as well as research institutions, they aim to revolutionize approaches to vaccine development, immune engineering, antibody discovery, and cell therapy. Generated from the website

HepaTx Corporation, based in Palo Alto, CA, is focused on developing off-the-shelf cell therapies for liver disease, utilizing advanced regenerative medicine technologies. With over 30 million Americans affected by liver disease and only a fraction able to receive necessary transplants, HepaTx aims to provide innovative treatment alternatives to improve patient outcomes. The company prides itself on its scalable manufacturing processes and a curated team of experts dedicated to revolutionizing liver care. By fostering collaboration with entrepreneurial pioneers and distinguished investors, HepaTx is committed to educating the public on accessible alternatives to liver transplantation. Generated from the website

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.